These benefits, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two assistance the notion of targeting ACKR3 as a unique solution to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. A study study posted in Anesthesiology https://baruchx816ikm0.blogolenta.com/profile